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Background/aim: The purpose of this study was to observe whether islet transplantation could induce glomerular parietal epithelial
cells to express podocyte proteins in a rat model of streptozotocin-induced diabetic nephropathy (DN).
Materials and methods: A total of 18 rats were given single injections of streptozotocin to induce a DN model. Eight weeks after the
modeling, successfully established DN rats were divided into three groups: an untreated group (DN group), an islet-transplanted group
(IT group), and an insulin group (IN group). The islets cells were isolated from donor rats and surgically transplanted from under
the kidney capsule in the IT group. Four weeks after treatment, pathological changes in the kidney were observed by pathological
staining and electron microscopy. Immunohistochemical staining for PAX-2, Ki-67, and synaptopodin was performed to evaluate cell
proliferation in the kidney tissues.
Results: After 4 weeks of treatment, islet transplantation significantly alleviated damage to the podocytes and increased the number
of glomerular transition cells compared to the DN and IN groups, which were defined as cells that double-stained for PAX-2 and
synaptopodin in membranous nephropathy. The results of HE staining, PAS staining, and electron microscopy detection also showed
that pathological changes were alleviated after islet transplantation.
Conclusion: IT restored the glomerular filtration barrier based on the regeneration of podocytes in the DN model rats, and this may
provide a promising clinical therapeutic strategy for human diabetes mellitus.
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1. Introduction
Diabetic nephropathy (DN) is the most common cause
of end-stage renal disease (ESRD) and accounts for
more than 25% of all ESRD cases in China (1,2). The
initiation and progression of DN is associated with
podocyte injury and loss. It has been reported that
the podocyte population can be restored and that this
process is linked to the regression of DN (3).
Islet
transplantation
(IT)
and
pancreas
transplantation are the most effective measures to
counteract type 1 diabetes (4,5). It has been reported
that IT can ameliorate albuminuria and alleviate
damage to the kidney (6). We have previously
demonstrated that IT can directly modify the barrier
of glomerular filtration by ameliorating damage to the
podocytes and the glomeruli basement membrane
(7). However, the mechanisms that underlie how the
barrier for glomerular filtration improves currently
remain elusive.
* Correspondence: jief67@sina.com

Recent studies have demonstrated that podocytes can
regenerate from parietal epithelial cell (PEC) progenitors
in human DN and in a diabetic mouse model (8,9).
In this study, we examined whether IT induces PECs
to express podocyte proteins. The amelioration of the
structure and function of podocytes is a crucial factor
in the process of recovery of early diabetic nephropathy.
Thus, an increased focus on podocytes may be beneficial
in the treatment of DN in clinical practice.
2. Materials and methods
2.1. Animals
This experimental study was conducted at Wenzhou
Medical University. Thirty-six male Sprague Dawley (SD)
rats at 8 weeks of age (body weight: 200–220 g) were
obtained from the Laboratory Animal Center of Wenzhou
Medical University. Eighteen of these rats were used to
establish the DN models and the others were used as donor
rats. All rats were housed with a 12:12-h light/dark cycle
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at 24 ± 1 °C and provided water and food ad libitum. All
animal procedures were based on international guidelines
and were approved by the Wenzhou Medical University
Animal Policy and Welfare Committee.
A rat diabetic model was induced by a single peritoneal
injection of streptozotocin (55 mg/kg) in sodium citrate
buffer (pH 4.5) after overnight fasting. Plasma glucose
levels were detected using drops of tail vein blood and a
glucometer (Roche, Indianapolis, IN, USA). One week
later, when the nonfasted blood glucose level was ≥16
mmol/L for more than 2 consecutive days, the rat diabetic
model was considered to be successfully established.
At 8 weeks after diabetes induction, the rats were
randomly divided into the following four groups: an
untreated group (DN group, n = 6), in which the rats were
left untreated; an islet-transplanted group (IT group, n =
6) that underwent islet transplantation under the kidney
capsule; an insulin treatment group (IN group, n = 6),
in which the rats were given insulin via subcutaneous
injection at 0900 and 2100 hours every day (each injection
was 3–8 U); and a control group (NC group, n = 6) that
consisted of nondiabetic rats.
2.2. Islet transplantation
Islets were isolated from the rat pancreas using the
previously described methods. Briefly, the rats were
anesthetized with chloral hydrate and a laparotomy was
performed. After locating and ligating the entrance of
the common bile duct into the intestine, the islets were
harvested by a reverse perfusion of 8 mL of collagenase
V (0.8 mg/mL, dissolved with Hanks solution) into the
common bile duct and purification with Histopaque-1119
and -1077 (Sigma-Aldrich, St Louis, MO, USA) density
gradient at 2000 rpm for 5 min. The final purified islets
were handpicked and transferred to a culture dish. The
purified islet cells were incubated overnight in cell culture
medium with 10% fetal bovine serum at 37 °C in 5% CO2.
Total islet equivalents were calculated according to the
islet equivalents (IEQ) calculation formula. Approximately
800–1000 IEQ islets from two donors (SD rats) were
transplanted under the kidney capsules of the diabetic rats.
2.3. Tissue sampling and staining
The nonfasting blood glucose levels of all groups were
measured twice per week throughout the experimental
period. Four weeks after islet transplantation, all rats were
humanely sacrificed and the tissue samples were harvested.
The renal tissues were placed in a 4% paraformaldehyde
solution and 2.5% glutaraldehyde for histopathological
analyses.
The kidney tissues were embedded in paraffin and cut
into 4-µm sections for measurement. The sections were
dewaxed with xylene, and the endogenous peroxidase
was blocked with 3% hydrogen peroxide. Heat-mediated
antigen retrieval was performed with a citrate buffer (pH
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6.0) before commencing with the IHC staining protocol.
The sections were then blocked for 10 min with 5% goat
serum (Boster, Hubei, China). Indirect immunoperoxidase
staining of the tissue sections was performed and the
samples were incubated overnight with primary antibodies
for PAX-2 and Ki-67 (Abcam, Shanghai, China) at 4 °C.
The tissue sections were then washed with phosphatebuffered saline (PBS, 0.01 M), incubated with secondary
antibodies, and visualized with diaminobenzidine (DAB,
brown color, ZSGB-BIO, Beijing, China) and hematoxylin
counterstaining under a microscope. More than 10 fields
in each section of each group were evaluated. The mean
value was used and the scoring was performed on blinded
slides.
2.4. Double immunohistochemistry staining
The paraffin tissue sections were dewaxed in xylene and
rehydrated in a gradient of alcohol solutions. The sections
were then washed with distilled water and the endogenous
peroxidase was blocked with 3% hydrogen peroxide.
Heat-mediated antigen retrieval was performed with
citrate buffer at pH 6 before commencing the staining
protocol. The sections were then blocked for 10 min with
5% goat serum. Indirect immunoperoxidase staining of
the tissue sections was performed, and the samples were
incubated overnight with primary antibodies for PAX2 and synaptopodin at 4 °C. The tissue sections were
subsequently rewarmed at 37 °C and incubated with
antirabbit IgG-FITC and antimouse IgG-Cy3 secondary
antibodies. After staining the nuclei with Hoechst staining
solution, the sections were visualized and measured under
a fluorescence microscope. More than 10 fields in each
section of each group were evaluated. The mean value was
used and the scoring was performed on blinded slides.
2.5. Transmission electron microscopy
The renal cortex tissue was cut into small pieces and
fixed in the glutaraldehyde solution. The renal tissues
were then washed with PBS and fixed with 1% osmium
tetroxide. After dehydration in an acetone gradient and
embedment with Araldite M (Sigma-Aldrich), the tissues
were stained with uranyl acetate and lead citrate (10).
The microstructures were detected under a Philips 301
electron microscope. The changes in the podocytes were
measured and assessed with Image-Pro Plus 6.0 image
analysis software.
2.6. Statistical analysis
We used a freehand line selection tool to draw a line along
the Bowman’s basement membrane (BBM) and to draw
around the glomerular tuft. BBM length and glomerular
tuft area results were then acquired from calculations of
the pixel numbers with Image J (National Institutes of
Health, Bethesda, MD, USA). All of the statistical data
were analyzed using SPSS 19 (IBM Corp., Armonk, NY,
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USA) and the values were expressed as means ± standard
deviations. Multiple comparisons between groups were
calculated with one-way ANOVA. A nonparametric
statistical method (chi-square test) was also used in this
study. The differences between groups were considered to
be significant at P < 0.05.
3. Results
3.1. Blood glucose concentrations levels in each group
In this study, the level of blood glucose (BG) in the DN
group was 28.6 ± 0.58 mmol/L. Compared to the DN group,
the BG levels of the IT and IN groups clearly decreased.
The IT group was able to more effectively control the BG
level than the IN group (7.02 ± 0.35 mmol/L versus 10.28
± 1.17 mmol/L, respectively; P< 0.01).
3.2. Pathological staining of the renal tissues of the
different groups
As demonstrated in Figure 1, periodic acid-Schiff staining
(PAS, Figure 1A) and hematoxylin-eosin (H&E) staining
(Figure 1B) of the renal tissues were performed to observe
the histopathological changes in the tubules and glomeruli
of each group. The results of PAS and H&E staining
revealed that the glomerular capillary loops and local
basement membranes were significantly thickened in the
DN group and IN group; mesangial matrix hyperplasia
was also evident. However, in the IT group, the glomerular
capillary loops were thin and transparent, and there was no
evident thickening of the basement membrane. Compared
to the IN and DN groups, the pathological changes were
significantly improved in the rats in the IT group, and
the renal damage caused by diabetic nephropathy was
ameliorated after islet transplantation.

3.3. Damage to the podocytes in each group
IT was an effective strategy for recovering the glomerular
filtration barrier in the DN rats. Via electron microscopy,
we have previously reported that IT can modify podocyte
depletion with foot process fusion in DN rats (Figure 2A).
3.4. Number of cells expressing PAX-2 protein along the
BBM in each group
It has been reported that the PAX-2 protein is normally
restricted to PECs in the glomerulus (11). PAX-2
immunostaining was observed in all groups (Figure
2B). The cells expressing PAX-2 along the BBM were
significantly increased in the DN group compared to
the control group (24.15 ± 1.21 versus 1.83 ± 0.18/mm,
respectively; P < 0.01). The number of cells that expressed
this protein in the IT group was significantly increased
compared to the DN group (39.03 ± 1.33 versus 24.15 ±
1.21/mm, respectively; P < 0.01). The average number of
PAX-2-expressing cells was not different between the DN
and IN groups (P > 0.05).
3.5. Number of cells expressing the Ki-67 protein along
the BBM in each group
To confirm and compare the effects of IT on the
proliferation of PECs along the BBM in the DN rats,
Ki-67 immunostaining was performed (Figure 2C). The
protein expression of Ki-67 along the BBM was rarely
found in the normal rats. However, in the IN group, the
expression of Ki-67 was increased compared to that of the
DN group (8.77 ± 0.58 versus 6.5 ± 0.38, respectively; P
< 0.01), while it was significantly lower compared to the
IT group (8.77 ± 0.58 versus 19.10 ± 1.06, respectively; P
< 0.05).

Figure 1. Pathological staining of the renal tissues was performed to observe the histopathological changes in the tubules and
glomeruli of each group: a) PAS staining in each group (original magnification 400×); b) H&E staining in each group (original
magnification 400×).
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Figure 2. Immunohistochemical staining and electron microscope detection were performed to assess the structures of the
podocytes in each group. A–D: 1) control group; 2) DN group; 3) IN group; 4) IT group. A1–A4: Structures of the podocytes based
on electron microscopy (original magnification 20,000×); B1–B4: immunohistochemical staining for PAX-2 (original magnification
400×); C1–C4: immunohistochemical staining for Ki-67 (original magnification 400×); D1–D4: double immunostaining for PAX2 and synaptopodin (original magnification 400×).

3.6. Number of glomerular cells expressing PAX-2 and
synaptopodin in each group
To determine whether IT increased the numbers of
glomerular epithelial transition cells (defined as cells in
the glomeruli that expressed both PEC and podocyte-
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specific protein), double immunostaining was performed
for PAX-2 and synaptopodin (Figure 2D). IT significantly
increased the number of transition cells compared to the
IN and DN groups (1.65 ± 0.19 versus 0.5 ± 0.10; P < 0.01
and 1.65 ± 0.19 versus 0.4 ± 0.09, respectively; P < 0.01).
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4. Discussion
Over the past few years, islet transplantation has emerged as
a promising therapeutic method in the use of conventional
antidiabetic drugs and insulin for the treatment of diabetic
patients. Although we have previously reported that IT
can improve the damage done to podocytes by inhibiting
the TGF-β1 pathway, the current study was designed to
determine whether IT could induce the expression of
podocyte proteins by parietal epithelial cells. The data
from our study demonstrated that proliferation of PECs
along the BBM and the numbers of glomerular transition
cells expressing both PEC- and podocyte-specific proteins
were increased in the DN rats after transplantation.
Podocytes are highly differentiated epithelial cells in
the glomeruli that are attached to the glomerular basement
membrane (GBM) to maintain an efficient glomerular
filtration mechanism (3,12,13). Their interdigitating foot
processes are bridged by slit diaphragms and control
patency via transcytosis clearance mechanisms. Studies
have demonstrated that decreases in podocyte numbers
and densities are critical determinants for the development
of proteinuria and progressive glomerulosclerosis in DN
(14,15). It has been reported that the glomerular PECs
lining Bowman’s capsule can function as progenitor cell
niches for podocytes and, in several forms of glomerular
disease, these cells can proliferate and transdifferentiate
into podocytes (16). The recovery of podocytes is a
crucial factor in the process of treating early DN. Thus,
podocytes may be a promising target in treating clinical
DN. In recent years, remarkable clinical human results
have been achieved in the application of islet transplant.
In addition, researchers have shown that the kidney graft
survival rates for uremic patients with diabetes mellitus
can be significantly improved after islet transplant. The
results of this study have demonstrated that the numbers
of transitional cells expressing both the PEC phenotypic
marker PAX-2 and the podocyte marker synaptopodin
were increased in the IT group, and these cells were only
rarely found in the IN and DN groups. These results
demonstrate that islet transplantation can significantly

ameliorate the thickening of the GBM and podocyte
damage with fusion of the foot processes.
However, the precise mechanisms underlying how DN
might induce PECs to begin to express podocyte protein is
unclear. Several studies have suggested that hyperglycemia
can promote podocyte apoptosis in the early stages, which
consequently induces PECs, along with Bowman’s capsule
activation, and proliferation and transdifferentiation of
podocytes (3,17,18). PEC activation might be mediated
via several transduction pathways that include Notch,
Wnt/β-catenin, and HB-EGF/EGFR (19–21). In this study,
we found that the activation and proliferation of PEC cells
were clearly increased in the hyperglycemic state. However,
there were more glomerular transition cells in the IT group
than in the other groups. We hypothesize that long-term
high BG leads to the induction of the actions of fibrotic
factors and cytokines, such as TGF-β1, HGF, and CTGF.
These overexpressions persistently promote podocyte and
PEC apoptosis and hamper the differentiation of PECs into
podocytes that repair damage in advanced DN. Normal
control of BG after IT has been verified in earlier studies
(22,23). The results of the present study also indicate
that IT exhibited increased benefits in terms of repairing
glomerular structure and kidney fibrosis, more so than
insulin therapy in DN model rats.
The results of this study also demonstrate that islet
transplantation could ameliorate podocyte damage in
early DN model rats. The recovery of impaired podocyte
function and microstructure is the key to treating diabetic
nephropathy. In this study, islet transplantation under
the kidney capsule significantly alleviated the impaired
microscopic damages of podocytes in DN rats. These
effects may be based on several signaling pathways during
the process of development and recovery of podocytes. To
the best of our knowledge, this is the first demonstration
that IT restores the glomerular filtration barrier through
the regeneration of podocytes in DN rats. These findings
may provide a new therapeutic method or preventive
treatment for early human DN and other complications
related to diabetes mellitus in the future.
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